Argus Research Maintains Buy on MetLife, Raises Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Argus Research has maintained its Buy rating on MetLife (NYSE:MET) and raised the price target from $77 to $80, indicating confidence in the company's future performance.
May 22, 2024 | 3:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Argus Research has maintained its Buy rating on MetLife and raised the price target from $77 to $80, reflecting a positive outlook on the company's future performance.
The raised price target and maintained Buy rating from Argus Research suggest strong confidence in MetLife's future performance. This is likely to positively impact the stock price in the short term as investors react to the optimistic outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100